glp-1 analog drugs Receptor Agonists as Treatments for Type 2 Diabetes The Impact of GLP-1 Receptor
Description
According to their findings, 53.6% discontinued GLP-1 treatment by the end of year one, with higher rates of discontinuation (64.8%) seen among those using the drugs solely for weight loss, when compared with the 46.5% of those who quit after using the medications as a diabetes treatment

Awadallah MG, Amer GA, Fawzy RM, El-Melouk MS, Egila SS

In 2021, it was approved for chronic weight management as Wegovy

Our dietitian-led nutrition services focus on achieving a balanced and sustainable intake rather than aggressive restriction

Rather than focusing on weight loss alone, when preparing for pregnancy, working with a dietitian can help assess nutritional needs and support healthy habits, such as eating regularly

Metabolism 2020;113:154388.ArticlePubMed 73
